202 related articles for article (PubMed ID: 30146492)
1. Channelopathy as a SUDEP Biomarker in Dravet Syndrome Patient-Derived Cardiac Myocytes.
Frasier CR; Zhang H; Offord J; Dang LT; Auerbach DS; Shi H; Chen C; Goldman AM; Eckhardt LL; Bezzerides VJ; Parent JM; Isom LL
Stem Cell Reports; 2018 Sep; 11(3):626-634. PubMed ID: 30146492
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-Specific Deletion of Scn8a Mitigates Dravet Syndrome-Associated Sudden Death in Adults.
King DR; Demirtas M; Tarasov M; Struckman HL; Meng X; Nassal D; Moise N; Miller A; Min D; Soltisz AM; Anne MNK; Alves Dias PA; Wagnon JL; Weinberg SH; Hund TJ; Veeraraghavan R; Radwański PB
JACC Clin Electrophysiol; 2024 May; 10(5):829-842. PubMed ID: 38430092
[TBL] [Abstract][Full Text] [Related]
3. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.
Liu Y; Lopez-Santiago LF; Yuan Y; Jones JM; Zhang H; O'Malley HA; Patino GA; O'Brien JE; Rusconi R; Gupta A; Thompson RC; Natowicz MR; Meisler MH; Isom LL; Parent JM
Ann Neurol; 2013 Jul; 74(1):128-39. PubMed ID: 23821540
[TBL] [Abstract][Full Text] [Related]
4. Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome.
Auerbach DS; Jones J; Clawson BC; Offord J; Lenk GM; Ogiwara I; Yamakawa K; Meisler MH; Parent JM; Isom LL
PLoS One; 2013; 8(10):e77843. PubMed ID: 24155976
[TBL] [Abstract][Full Text] [Related]
5. A novel rat model of Dravet syndrome recapitulates clinical hallmarks.
Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H
Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.
Schuster J; Laan L; Klar J; Jin Z; Huss M; Korol S; Noraddin FH; Sobol M; Birnir B; Dahl N
Neurobiol Dis; 2019 Dec; 132():104583. PubMed ID: 31445158
[TBL] [Abstract][Full Text] [Related]
7. Life-span characterization of epilepsy and comorbidities in Dravet syndrome mice carrying a targeted deletion of exon 1 of the Scn1a gene.
Gerbatin RR; Augusto J; Boutouil H; Reschke CR; Henshall DC
Exp Neurol; 2022 Aug; 354():114090. PubMed ID: 35487274
[TBL] [Abstract][Full Text] [Related]
8. Sudden unexpected death in a mouse model of Dravet syndrome.
Kalume F; Westenbroek RE; Cheah CS; Yu FH; Oakley JC; Scheuer T; Catterall WA
J Clin Invest; 2013 Apr; 123(4):1798-808. PubMed ID: 23524966
[TBL] [Abstract][Full Text] [Related]
9. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides increase
Han Z; Chen C; Christiansen A; Ji S; Lin Q; Anumonwo C; Liu C; Leiser SC; Meena ; Aznarez I; Liau G; Isom LL
Sci Transl Med; 2020 Aug; 12(558):. PubMed ID: 32848094
[TBL] [Abstract][Full Text] [Related]
11. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene.
Tanaka Y; Sone T; Higurashi N; Sakuma T; Suzuki S; Ishikawa M; Yamamoto T; Mitsui J; Tsuji H; Okano H; Hirose S
Stem Cell Res; 2018 Apr; 28():100-104. PubMed ID: 29453127
[TBL] [Abstract][Full Text] [Related]
12. High-resolution molecular genomic autopsy reveals complex sudden unexpected death in epilepsy risk profile.
Klassen TL; Bomben VC; Patel A; Drabek J; Chen TT; Gu W; Zhang F; Chapman K; Lupski JR; Noebels JL; Goldman AM
Epilepsia; 2014 Feb; 55(2):e6-12. PubMed ID: 24372310
[TBL] [Abstract][Full Text] [Related]
13. Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line.
Shan W; Yang X; Ren Q; Wang Q
Stem Cell Res; 2021 Aug; 55():102452. PubMed ID: 34247112
[TBL] [Abstract][Full Text] [Related]
14. Mortality in Dravet syndrome.
Cooper MS; Mcintosh A; Crompton DE; McMahon JM; Schneider A; Farrell K; Ganesan V; Gill D; Kivity S; Lerman-Sagie T; McLellan A; Pelekanos J; Ramesh V; Sadleir L; Wirrell E; Scheffer IE
Epilepsy Res; 2016 Dec; 128():43-47. PubMed ID: 27810515
[TBL] [Abstract][Full Text] [Related]
15. SCN1A/Na
Mantegazza M; Broccoli V
Epilepsia; 2019 Dec; 60 Suppl 3():S25-S38. PubMed ID: 31904127
[TBL] [Abstract][Full Text] [Related]
16. Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.
Schuster J; Fatima A; Sobol M; Norradin FH; Laan L; Dahl N
Stem Cell Res; 2019 Aug; 39():101523. PubMed ID: 31400703
[TBL] [Abstract][Full Text] [Related]
17. Generation of a human iPSC line (UUIGPi015-A) from a patient with Dravet syndrome and a 2.9 Mb deletion spanning SCN1A on chromosome 2.
Schuster J; de Guidi C; Tripathi R; Klar J; Dahl N
Stem Cell Res; 2022 Apr; 60():102712. PubMed ID: 35203050
[TBL] [Abstract][Full Text] [Related]
18. The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model.
Zayat V; Kuczynska Z; Liput M; Metin E; Rzonca-Niewczas S; Smyk M; Mazurczak T; Goszczanska-Ciuchta A; Leszczynski P; Hoffman-Zacharska D; Buzanska L
Cells; 2023 Jan; 12(2):. PubMed ID: 36672274
[TBL] [Abstract][Full Text] [Related]
19. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.
Hawkins NA; Jurado M; Thaxton TT; Duarte SE; Barse L; Tatsukawa T; Yamakawa K; Nishi T; Kondo S; Miyamoto M; Abrahams BS; During MJ; Kearney JA
Epilepsia; 2021 Nov; 62(11):2845-2857. PubMed ID: 34510432
[TBL] [Abstract][Full Text] [Related]
20. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.
Mistry AM; Thompson CH; Miller AR; Vanoye CG; George AL; Kearney JA
Neurobiol Dis; 2014 May; 65():1-11. PubMed ID: 24434335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]